AI-based drug developer Basecamp valued at $800 million after $140 million funding round

The oversubscribed round was led by S32, with participation from Nvidia, Anthropic’s Anthology Fund, Catalio Capital Management, the NATO Innovation Fund, the Rockefeller Foundation and Singular, among other investors.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.